Robert Neil Goldstone, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 15 | 2024 | 1145 | 1.980 |
Why?
|
Colectomy | 7 | 2024 | 671 | 1.320 |
Why?
|
Laparoscopy | 8 | 2024 | 2134 | 1.170 |
Why?
|
Anus Neoplasms | 3 | 2017 | 327 | 1.170 |
Why?
|
Tunica Intima | 2 | 2018 | 456 | 0.980 |
Why?
|
Ileostomy | 1 | 2024 | 118 | 0.890 |
Why?
|
Colorectal Neoplasms | 10 | 2024 | 6793 | 0.880 |
Why?
|
Colonic Neoplasms | 9 | 2023 | 2503 | 0.830 |
Why?
|
Colitis, Ulcerative | 4 | 2023 | 1911 | 0.770 |
Why?
|
Intestinal Perforation | 2 | 2021 | 252 | 0.750 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 129 | 0.750 |
Why?
|
Photochemotherapy | 2 | 2018 | 808 | 0.730 |
Why?
|
HIV Seropositivity | 2 | 2017 | 957 | 0.660 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 155 | 0.640 |
Why?
|
Carcinoma in Situ | 2 | 2016 | 794 | 0.630 |
Why?
|
Precancerous Conditions | 4 | 2017 | 969 | 0.580 |
Why?
|
Colorectal Surgery | 1 | 2019 | 121 | 0.560 |
Why?
|
Anal Canal | 2 | 2017 | 371 | 0.560 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2023 | 2403 | 0.550 |
Why?
|
Photosensitizing Agents | 2 | 2018 | 608 | 0.540 |
Why?
|
Hyperplasia | 3 | 2018 | 1154 | 0.530 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 435 | 0.510 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2024 | 9207 | 0.480 |
Why?
|
Arteriovenous Fistula | 1 | 2018 | 312 | 0.480 |
Why?
|
Colitis | 1 | 2023 | 1219 | 0.480 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2018 | 288 | 0.470 |
Why?
|
Catheter Ablation | 2 | 2017 | 2724 | 0.450 |
Why?
|
Neoadjuvant Therapy | 7 | 2023 | 2789 | 0.440 |
Why?
|
Income | 1 | 2021 | 1864 | 0.410 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1129 | 0.400 |
Why?
|
Light Coagulation | 1 | 2011 | 72 | 0.400 |
Why?
|
Postoperative Complications | 9 | 2024 | 15437 | 0.390 |
Why?
|
Abdominal Abscess | 2 | 2022 | 151 | 0.370 |
Why?
|
HIV Seronegativity | 1 | 2011 | 207 | 0.360 |
Why?
|
Corneal Wavefront Aberration | 1 | 2010 | 7 | 0.360 |
Why?
|
Health Expenditures | 2 | 2022 | 2335 | 0.360 |
Why?
|
Homosexuality, Male | 3 | 2017 | 1253 | 0.350 |
Why?
|
Infrared Rays | 1 | 2011 | 241 | 0.350 |
Why?
|
Lasers, Excimer | 1 | 2010 | 70 | 0.340 |
Why?
|
Stromal Cells | 1 | 2015 | 1317 | 0.340 |
Why?
|
Adenocarcinoma | 6 | 2022 | 6306 | 0.330 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2010 | 85 | 0.330 |
Why?
|
Contact Lenses | 1 | 2010 | 132 | 0.320 |
Why?
|
Anastomosis, Surgical | 3 | 2021 | 977 | 0.300 |
Why?
|
Myopia | 1 | 2010 | 243 | 0.300 |
Why?
|
Retrospective Studies | 29 | 2024 | 79127 | 0.290 |
Why?
|
General Surgery | 1 | 2019 | 1642 | 0.290 |
Why?
|
Colonic Polyps | 1 | 2011 | 547 | 0.270 |
Why?
|
Colon | 3 | 2020 | 1781 | 0.270 |
Why?
|
Colonoscopy | 3 | 2022 | 1378 | 0.260 |
Why?
|
Neoplasm Staging | 11 | 2023 | 11064 | 0.260 |
Why?
|
Appendicitis | 2 | 2022 | 672 | 0.250 |
Why?
|
Colostomy | 1 | 2024 | 103 | 0.230 |
Why?
|
Medicare | 1 | 2022 | 6689 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4004 | 0.230 |
Why?
|
Matched-Pair Analysis | 1 | 2023 | 283 | 0.210 |
Why?
|
Emergencies | 2 | 2019 | 1176 | 0.210 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 86 | 0.210 |
Why?
|
Treatment Outcome | 13 | 2024 | 64245 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6501 | 0.200 |
Why?
|
Colon, Transverse | 1 | 2021 | 23 | 0.190 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 83 | 0.190 |
Why?
|
Hospitals, Community | 1 | 2023 | 361 | 0.180 |
Why?
|
Humans | 51 | 2024 | 752341 | 0.180 |
Why?
|
Aged | 18 | 2024 | 166562 | 0.180 |
Why?
|
Hospices | 1 | 2023 | 254 | 0.180 |
Why?
|
Anastomotic Leak | 1 | 2021 | 160 | 0.180 |
Why?
|
New York | 2 | 2020 | 872 | 0.170 |
Why?
|
Middle Aged | 21 | 2024 | 217019 | 0.170 |
Why?
|
Abdomen, Acute | 1 | 2019 | 122 | 0.160 |
Why?
|
Rectum | 2 | 2023 | 894 | 0.160 |
Why?
|
Cultural Competency | 1 | 2022 | 288 | 0.160 |
Why?
|
Diverticulitis | 1 | 2021 | 177 | 0.160 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2021 | 3489 | 0.160 |
Why?
|
Proctoscopy | 1 | 2017 | 40 | 0.150 |
Why?
|
Hospital Mortality | 2 | 2024 | 5369 | 0.150 |
Why?
|
Male | 25 | 2024 | 354881 | 0.150 |
Why?
|
Treatment Refusal | 1 | 2020 | 427 | 0.140 |
Why?
|
Disease-Free Survival | 5 | 2022 | 6781 | 0.140 |
Why?
|
Disease Progression | 2 | 2024 | 13402 | 0.140 |
Why?
|
Hospice Care | 1 | 2023 | 687 | 0.140 |
Why?
|
Metformin | 1 | 2023 | 895 | 0.130 |
Why?
|
Prognosis | 8 | 2022 | 29327 | 0.130 |
Why?
|
Rose Bengal | 1 | 2016 | 115 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1051 | 0.130 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2016 | 283 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2020 | 574 | 0.130 |
Why?
|
Sus scrofa | 1 | 2016 | 428 | 0.120 |
Why?
|
Adult | 15 | 2024 | 216913 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 533 | 0.120 |
Why?
|
Vascular Grafting | 1 | 2016 | 152 | 0.120 |
Why?
|
Elasticity | 1 | 2016 | 653 | 0.120 |
Why?
|
Reoperation | 1 | 2024 | 4256 | 0.110 |
Why?
|
Robotics | 1 | 2021 | 879 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1495 | 0.110 |
Why?
|
Female | 21 | 2024 | 386053 | 0.110 |
Why?
|
Saphenous Vein | 1 | 2016 | 527 | 0.110 |
Why?
|
Intestines | 1 | 2022 | 1896 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1907 | 0.100 |
Why?
|
Carotid Arteries | 1 | 2016 | 950 | 0.100 |
Why?
|
Papillomavirus Infections | 2 | 2017 | 1594 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1638 | 0.100 |
Why?
|
Terminal Care | 1 | 2023 | 1728 | 0.100 |
Why?
|
Swine | 2 | 2022 | 5883 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12137 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3106 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12455 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3288 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39079 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2021 | 1775 | 0.080 |
Why?
|
United States | 9 | 2024 | 71442 | 0.080 |
Why?
|
Refraction, Ocular | 1 | 2010 | 171 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3585 | 0.080 |
Why?
|
Appendectomy | 2 | 2022 | 424 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2018 | 972 | 0.080 |
Why?
|
Quality Improvement | 1 | 2024 | 3797 | 0.080 |
Why?
|
Age Factors | 2 | 2022 | 18297 | 0.080 |
Why?
|
Length of Stay | 4 | 2024 | 6372 | 0.080 |
Why?
|
Developing Countries | 1 | 2021 | 2819 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2483 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7211 | 0.080 |
Why?
|
Abscess | 2 | 2022 | 605 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1256 | 0.070 |
Why?
|
Risk Factors | 5 | 2023 | 73412 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3165 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11007 | 0.070 |
Why?
|
Crohn Disease | 1 | 2019 | 2256 | 0.070 |
Why?
|
Young Adult | 5 | 2021 | 57629 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8157 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1671 | 0.070 |
Why?
|
Graft Survival | 1 | 2016 | 3626 | 0.070 |
Why?
|
Alphapapillomavirus | 1 | 2008 | 218 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5397 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2022 | 7399 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3463 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3302 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1618 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8443 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10036 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13277 | 0.060 |
Why?
|
Abdomen | 1 | 2009 | 1112 | 0.060 |
Why?
|
Prospective Studies | 4 | 2024 | 53807 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2015 | 3285 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58300 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3521 | 0.050 |
Why?
|
Risk Assessment | 2 | 2023 | 23783 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12746 | 0.050 |
Why?
|
Cause of Death | 2 | 2024 | 3686 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5812 | 0.050 |
Why?
|
Rats | 1 | 2018 | 23562 | 0.050 |
Why?
|
Adolescent | 5 | 2021 | 86765 | 0.050 |
Why?
|
Visual Acuity | 1 | 2010 | 2591 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2868 | 0.050 |
Why?
|
Inpatients | 2 | 2023 | 2561 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2020 | 121 | 0.040 |
Why?
|
Time Factors | 2 | 2011 | 39854 | 0.040 |
Why?
|
RNA, Viral | 1 | 2008 | 2827 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2015 | 18915 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1892 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2018 | 17958 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2021 | 394 | 0.040 |
Why?
|
Developed Countries | 1 | 2021 | 440 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11422 | 0.040 |
Why?
|
Causality | 1 | 2024 | 1238 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13165 | 0.040 |
Why?
|
Animals | 3 | 2022 | 166802 | 0.040 |
Why?
|
SEER Program | 1 | 2021 | 1520 | 0.030 |
Why?
|
Nursing Homes | 1 | 2023 | 1059 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1538 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1590 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1294 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7898 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20843 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21808 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2924 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1838 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15130 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1912 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3755 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2400 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40984 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8538 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3653 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6170 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3474 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10475 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8362 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12869 | 0.020 |
Why?
|
Serum Albumin | 1 | 2009 | 676 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4714 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 21841 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21158 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5279 | 0.010 |
Why?
|
Diet | 1 | 2021 | 7949 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6058 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6743 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14586 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12898 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15676 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15506 | 0.010 |
Why?
|
Child | 1 | 2018 | 78998 | 0.010 |
Why?
|